Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 166

1.

Cardiovascular outcomes associated with canagliflozin versus other non-gliflozin antidiabetic drugs: population based cohort study.

Patorno E, Goldfine AB, Schneeweiss S, Everett BM, Glynn RJ, Liu J, Kim SC.

BMJ. 2018 Feb 6;360:k119. doi: 10.1136/bmj.k119.

2.

Linagliptin and cardiovascular outcomes in type 2 diabetes after acute coronary syndrome or acute ischemic stroke.

Li YR, Tsai SS, Chen DY, Chen ST, Sun JH, Chang HY, Liou MJ, Chen TH.

Cardiovasc Diabetol. 2018 Jan 4;17(1):2. doi: 10.1186/s12933-017-0655-y.

3.

Association of type 2 diabetes mellitus and ratio of transmitral E wave velocity to early diastole mitral velocity with cardiovascular events in chronic kidney disease.

Chen PC, Huang JC, Chen SC, Wu PY, Lee JJ, Chiu YW, Chang JM, Chen HC, Huang YL.

Oncotarget. 2017 Oct 10;8(55):94407-94416. doi: 10.18632/oncotarget.21768. eCollection 2017 Nov 7.

4.

Association Between Stroke Risk and Metformin Use in Hemodialysis Patients With Diabetes Mellitus: A Nested Case-Control Study.

Chien LN, Chou CL, Chen HH, Kao CC, Lin YC, Wu YL, Chen JS, Chen LY, Fang TC.

J Am Heart Assoc. 2017 Nov 16;6(11). pii: e007611. doi: 10.1161/JAHA.117.007611.

5.
6.

Subclinical atherosclerosis and history of cardiovascular events in Italian patients with rheumatoid arthritis: Results from a cross-sectional, multicenter GIRRCS (Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale) study.

Ruscitti P, Margiotta DPE, Macaluso F, Iacono D, D'Onofrio F, Emmi G, Atzeni F, Prete M, Perosa F, Sarzi-Puttini P, Emmi L, Cantatore FP, Triolo G, Afeltra A, Giacomelli R, Valentini G.

Medicine (Baltimore). 2017 Oct;96(42):e8180. doi: 10.1097/MD.0000000000008180.

7.

Impact of type 2 diabetes mellitus on in-hospital-mortality after major cardiovascular events in Spain (2002-2014).

de Miguel-Yanes JM, Jiménez-García R, Hernández-Barrera V, Méndez-Bailón M, de Miguel-Díez J, Lopez-de-Andrés A.

Cardiovasc Diabetol. 2017 Oct 10;16(1):126. doi: 10.1186/s12933-017-0609-4.

8.

Serum cystatin C is associated with large cerebral artery stenosis in acute ischemic stroke.

Xu Z, Leng C, Yang B, Wang H, Sun J, Liu Z, Yang L, Ge W, Zhu J.

Oncotarget. 2017 May 22;8(40):67181-67188. doi: 10.18632/oncotarget.18061. eCollection 2017 Sep 15.

9.

Moderate- to high-intensity statins for secondary prevention in patients with type 2 diabetes mellitus on dialysis after acute myocardial infarction.

Li YR, Tsai SS, Lin YS, Chung CM, Chen ST, Sun JH, Liou MJ, Chen TH.

Diabetol Metab Syndr. 2017 Sep 19;9:71. doi: 10.1186/s13098-017-0272-7. eCollection 2017.

10.

Anti-inflammatory Effect of Glucagon Like Peptide-1 Receptor Agonist, Exendin-4, through Modulation of IB1/JIP1 Expression and JNK Signaling in Stroke.

Kim S, Jeong J, Jung HS, Kim B, Kim YE, Lim DS, Kim SD, Song YS.

Exp Neurobiol. 2017 Aug;26(4):227-239. doi: 10.5607/en.2017.26.4.227. Epub 2017 Aug 31.

11.

Association between carotid plaque characteristics and acute cerebral infarction determined by MRI in patients with type 2 diabetes mellitus.

Sun B, Li X, Liu X, Ge X, Lu Q, Zhao X, Pu J, Xu J, Zhao H.

Cardiovasc Diabetol. 2017 Sep 11;16(1):111. doi: 10.1186/s12933-017-0592-9.

12.

Reduced Antiplatelet Effect of Aspirin Does Not Predict Cardiovascular Events in Patients With Stable Coronary Artery Disease.

Larsen SB, Grove EL, Neergaard-Petersen S, Würtz M, Hvas AM, Kristensen SD.

J Am Heart Assoc. 2017 Aug 5;6(8). pii: e006050. doi: 10.1161/JAHA.117.006050.

13.

Type 2 diabetes, glucose, insulin, BMI, and ischemic stroke subtypes: Mendelian randomization study.

Larsson SC, Scott RA, Traylor M, Langenberg CC, Hindy G, Melander O, Orho-Melander M, Seshadri S, Wareham NJ, Markus HS; METASTROKE Collaboration and NINDS Stroke Genetics Network (SiGN).

Neurology. 2017 Aug 1;89(5):454-460. doi: 10.1212/WNL.0000000000004173. Epub 2017 Jun 30.

14.

Echocardiography and Electrocardiography Variables Correlate With the New York Heart Association classification: An Observational Study of Ischemic Cardiomyopathy Patients.

Hu Y, Jiang S, Lu S, Xu R, Huang Y, Zhao Z, Qu Y.

Medicine (Baltimore). 2017 Jun;96(26):e7071. doi: 10.1097/MD.0000000000007071.

15.
16.

Macrovascular Complications and Prevalence of Urgency Incontinence in Japanese Patients with Type 2 Diabetes Mellitus: The Dogo Study.

Furukawa S, Sakai T, Niiya T, Miyaoka H, Miyake T, Yamamoto S, Kanzaki S, Maruyama K, Tanaka K, Ueda T, Senba H, Torisu M, Minami H, Onji M, Tanigawa T, Matsuura B, Hiasa Y, Miyake Y.

Intern Med. 2017;56(8):889-893. doi: 10.2169/internalmedicine.56.8063. Epub 2017 Apr 15.

17.

Synergistic Effect of the <i>MTHFR</i> C677T and <i>EPHX2</i> G860A Polymorphism on the Increased Risk of Ischemic Stroke in Chinese Type 2 Diabetic Patients.

Ma L, Jiang Y, Kong X, Yan M, Zhao T, Zhao H, Liu Q, Zhang H, Cao Y, Li P.

J Diabetes Res. 2017;2017:6216205. doi: 10.1155/2017/6216205. Epub 2017 Mar 20.

18.

Empagliflozin and Cerebrovascular Events in Patients With Type 2 Diabetes Mellitus at High Cardiovascular Risk.

Zinman B, Inzucchi SE, Lachin JM, Wanner C, Fitchett D, Kohler S, Mattheus M, Woerle HJ, Broedl UC, Johansen OE, Albers GW, Diener HC; EMPA-REG OUTCOME Investigators (Empagliflozin Cardiovascular Outcome Event Trial in Type 2 Diabetes Mellitus Patients).

Stroke. 2017 May;48(5):1218-1225. doi: 10.1161/STROKEAHA.116.015756. Epub 2017 Apr 6.

20.

Supplemental Content

Loading ...
Support Center